Following negotiations with Roche, Romgermed decided to buy technology from the Swiss group, the company said.
Romgermed was set up in 1999 and owns several medical centers and medical labs countrywide. It is controlled by Dorian Sam Schwartz with 95% of the shares and by Filip Florin Schwartz, who owns the remainder.
Romgermed is currently building a hospital in Bucharest and the project is worth EUR20 million.